Comparative Accuracy of Focused Cardiac Ultrasonography and Clinical Examination for Left Ventricular Dysfunction and Valvular Heart Disease: A Systematic Review and Meta-analysis.


Journal

Annals of internal medicine
ISSN: 1539-3704
Titre abrégé: Ann Intern Med
Pays: United States
ID NLM: 0372351

Informations de publication

Date de publication:
20 08 2019
Historique:
pubmed: 6 8 2019
medline: 17 6 2020
entrez: 6 8 2019
Statut: ppublish

Résumé

Incorporating focused cardiac ultrasonography (FoCUS) into clinical examination could improve the diagnostic yield of bedside patient evaluation. To compare the accuracy of FoCUS-assisted clinical assessment versus clinical assessment alone for diagnosing left ventricular dysfunction or valvular disease in adults having cardiovascular evaluation. English-language searches of MEDLINE, Embase, and Web of Science from 1 January 1990 to 23 May 2019 and review of reference citations. Eligible studies were done in patients having cardiovascular evaluation; compared FoCUS-assisted clinical assessment versus clinical assessment alone for the diagnosis of left ventricular systolic dysfunction, aortic or mitral valve disease, or pericardial effusion; and used transthoracic echocardiography as the reference standard. Three study investigators independently abstracted data and assessed study quality. Nine studies were included in the meta-analysis. The sensitivity of clinical assessment for diagnosing left ventricular dysfunction (left ventricular ejection fraction <50%) was 43% (95% CI, 33% to 54%), whereas that of FoCUS-assisted examination was 84% (CI, 74% to 91%). The specificity of clinical assessment was 81% (CI, 65% to 90%), and that of FoCUS-assisted examination was 89% (CI, 85% to 91%). The sensitivities of clinical assessment and FoCUS-assisted examination for diagnosing aortic or mitral valve disease (of at least moderate severity) were 46% (CI, 35% to 58%) and 71% (CI, 63% to 79%), respectively. Both the clinical assessment and the FoCUS-assisted examination had a specificity of 94% (CI, 91% to 96%). Evidence was scant, persons doing ultrasonography had variable skill levels, and most studies had unclear or high risk of bias. Clinical examination assisted by FoCUS has greater sensitivity, but not greater specificity, than clinical assessment alone for identifying left ventricular dysfunction and aortic or mitral valve disease; FoCUS-assisted examination may help rule out cardiovascular pathology in some patients, but it may not be sufficient for definitive confirmation of cardiovascular disease suspected on physical examination. None. (PROSPERO: CRD42019124318).

Sections du résumé

Background
Incorporating focused cardiac ultrasonography (FoCUS) into clinical examination could improve the diagnostic yield of bedside patient evaluation.
Purpose
To compare the accuracy of FoCUS-assisted clinical assessment versus clinical assessment alone for diagnosing left ventricular dysfunction or valvular disease in adults having cardiovascular evaluation.
Data Sources
English-language searches of MEDLINE, Embase, and Web of Science from 1 January 1990 to 23 May 2019 and review of reference citations.
Study Selection
Eligible studies were done in patients having cardiovascular evaluation; compared FoCUS-assisted clinical assessment versus clinical assessment alone for the diagnosis of left ventricular systolic dysfunction, aortic or mitral valve disease, or pericardial effusion; and used transthoracic echocardiography as the reference standard.
Data Extraction
Three study investigators independently abstracted data and assessed study quality.
Data Synthesis
Nine studies were included in the meta-analysis. The sensitivity of clinical assessment for diagnosing left ventricular dysfunction (left ventricular ejection fraction <50%) was 43% (95% CI, 33% to 54%), whereas that of FoCUS-assisted examination was 84% (CI, 74% to 91%). The specificity of clinical assessment was 81% (CI, 65% to 90%), and that of FoCUS-assisted examination was 89% (CI, 85% to 91%). The sensitivities of clinical assessment and FoCUS-assisted examination for diagnosing aortic or mitral valve disease (of at least moderate severity) were 46% (CI, 35% to 58%) and 71% (CI, 63% to 79%), respectively. Both the clinical assessment and the FoCUS-assisted examination had a specificity of 94% (CI, 91% to 96%).
Limitation
Evidence was scant, persons doing ultrasonography had variable skill levels, and most studies had unclear or high risk of bias.
Conclusion
Clinical examination assisted by FoCUS has greater sensitivity, but not greater specificity, than clinical assessment alone for identifying left ventricular dysfunction and aortic or mitral valve disease; FoCUS-assisted examination may help rule out cardiovascular pathology in some patients, but it may not be sufficient for definitive confirmation of cardiovascular disease suspected on physical examination.
Primary Funding Source
None. (PROSPERO: CRD42019124318).

Identifiants

pubmed: 31382273
pii: 2747507
doi: 10.7326/M19-1337
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

264-272

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Auteurs

Jeffrey A Marbach (JA)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada (J.A.M., R.J., T.S.).

Aws Almufleh (A)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada, and King Saud University, Riyadh, Saudi Arabia (A.A.).

Pietro Di Santo (P)

University of Ottawa Heart Institute and University of Ottawa School of Epidemiology and Public Health, Ottawa, Ontario, Canada (P.D., M.M., J.S.).

Richard Jung (R)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada (J.A.M., R.J., T.S.).

Trevor Simard (T)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada (J.A.M., R.J., T.S.).

Matthew McInnes (M)

University of Ottawa Heart Institute and University of Ottawa School of Epidemiology and Public Health, Ottawa, Ontario, Canada (P.D., M.M., J.S.).

Jean-Paul Salameh (JP)

University of Ottawa Heart Institute and University of Ottawa School of Epidemiology and Public Health, Ottawa, Ontario, Canada (P.D., M.M., J.S.).

Trevor A McGrath (TA)

University of Ottawa School of Epidemiology and Public Health, Ottawa, Ontario, Canada; University of Ottawa, Ottawa, Ontario, Canada (T.A.M., S.J.M.).

Scott J Millington (SJ)

University of Ottawa School of Epidemiology and Public Health, Ottawa, Ontario, Canada; University of Ottawa, Ottawa, Ontario, Canada (T.A.M., S.J.M.).

Gretchen Diemer (G)

Thomas Jefferson University, Philadelphia, Pennsylvania (G.D., F.M.W.).

Frances Mae West (FM)

Thomas Jefferson University, Philadelphia, Pennsylvania (G.D., F.M.W.).

Marie-Cecile Domecq (MC)

University of Ottawa Health Sciences Library, Ottawa, Ontario, Canada (M.D.).

Benjamin Hibbert (B)

University of Ottawa Heart Institute and University of Ottawa, Ottawa, Ontario, Canada (B.H.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH